Lipitor and Concomitant disease progression - a phase IV clinical study of FDA data

Summary:

Concomitant disease progression is reported as a side effect among people who take Lipitor (atorvastatin calcium), especially for people who are male, 60+ old, have been taking the drug for 1 - 6 months also take Lasix, and have Diabetes.

The phase IV clinical study analyzes which people have Concomitant disease progression when taking Lipitor. It is created by eHealthMe based on reports of 251,142 people who have side effects when taking Lipitor from the FDA, and is updated regularly.

What is Lipitor?

Lipitor has active ingredients of atorvastatin calcium. It is often used in high blood cholesterol. eHealthMe is studying from 259,047 Lipitor users. Check the latest studies of Lipitor.

What is Concomitant disease progression?

Concomitant disease progression (progress in accompanying disease) is found to be associated with 372 drugs and 622 conditions by eHealthMe. Check the latest studies of Concomitant disease progression.

On Jul, 14, 2026

251,142 people reported to have side effects when taking Lipitor.
Among them, 80 people (0.03%) have Concomitant disease progression.

Could Lipitor cause Concomitant disease progression?

Among these 80 people:

How long have people been on Lipitor when they have Concomitant disease progression? *

What is the gender of people who have Concomitant disease progression when taking Lipitor? *

female: 37.5 %
male: 62.5 %

What is the age of people who have Concomitant disease progression when taking Lipitor? *

What are other drugs people take besides Lipitor? *

What are other side effects people have besides Concomitant disease progression? *

Stress And Anxiety: 24 people, 30.00%
Abdominal Pain: 19 people, 23.75%
Osteonecrosis Of Jaw (death of bone of jaw): 19 people, 23.75%
Metastases To Spine (cancer spreads to spine): 19 people, 23.75%
Anaemia (lack of blood): 18 people, 22.50%
Kidney Stones: 18 people, 22.50%
Back Pain: 18 people, 22.50%
Headache (pain in head): 17 people, 21.25%
Hyperglycemia (high blood sugar): 16 people, 20.00%
Conjunctivitis (pink eye): 16 people, 20.00%

What are the existing conditions these people have? *

Diabetes: 11 people, 13.75%
Constipation: 8 people, 10.00%
Diabetic Retinopathy (damage to the retina caused by complications of diabetes): 7 people, 8.75%
Varices Oesophageal (enlarged and swollen veins at the bottom of the oesophagus, near the stomach): 6 people, 7.50%
Hepatic Steatosis (fatty liver disease): 6 people, 7.50%
Fluid Retention (an abnormal accumulation of fluid in the blood): 6 people, 7.50%
Menopausal Symptoms: 6 people, 7.50%
Sleep Disorder: 6 people, 7.50%
Heart Disease: 5 people, 6.25%
Muscle Cramps (painful sensations caused by muscle contraction): 5 people, 6.25%

* Approximation only. Some reports may have incomplete information.

Do you take Lipitor and have Concomitant disease progression?

- Check whether Concomitant disease progression is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Lipitor:

Lipitor (259,047 reports)

Browse all side effects of Lipitor:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Concomitant disease progression:

Concomitant disease progression (372 drugs)

Browse all the conditions that are associated with Concomitant disease progression:

Concomitant disease progression (622 conditions)

Related publications that referenced our studies

Proti? D, Balti? S, Stupar N, Pavlov-Dolijanovi? S, Mugo?a S, Todorovi? Z, "A case of myositis with immunological background associated with statin use", Open Medicine, 2014 Oct .
Goldie MP, "Atorvastatin: a new treatment for periodontal disease?", , 2012 Jan .
Proti? D, Balti? S, Stupar N, Pavlov-Dolijanovi? S, Mugo?a S, Todorovi? Z, "A case of myositis with immunological background associated with statin use", Open Medicine, 2014 Oct .
Goldie MP, "Atorvastatin: a new treatment for periodontal disease?", , 2012 Jan .

How the study uses the data?

The study uses data from the FDA. It is based on atorvastatin calcium (the active ingredients of Lipitor) and Lipitor (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.